Table 4.
Risk Factor | Comorbid | Somatic | Affective | |||
---|---|---|---|---|---|---|
OR | 95%CI | OR | 95%CI | OR | 95%CI | |
Diagnosis | ||||||
Solid tumors | 1.0 | 1.0 | 1.0 | |||
Bone and soft tissue sarcomas | 1.26 | 1.01–1.57 | 0.99 | 0.82–1.20 | 1.15 | 0.95–1.40 |
CNS tumors | 1.30 | 1.05–1.61 | 0.88 | 0.73–1.06 | 1.29 | 1.08–1.55 |
Leukemia | 1.34 | 1.12–1.61 | 0.88 | 0.75–1.03 | 1.04 | 0.88–1.22 |
Lymphomas | 1.16 | 0.93–1.44 | 0.97 | 0.80–1.16 | 1.17 | 0.97–1.41 |
Age at diagnosis (per year) | 1.01 | 0.99–1.02 | 1.02 | 1.01–1.03 | 0.98 | 0.97–0.99 |
Time since diagnosis (per year) | 1.01 | 0.99–1.02 | 1.01 | 1.00–1.02 | 0.98 | 0.97–0.99 |
Note. Solid tumors include Wilms tumor and neuroblastoma. Adjusted for sex and race. Risk for comorbid, somatic and affective cluster membership referenced to the asymptomatic cluster. OR associated with age at diagnosis based on each year older, and time since diagnosis based on each year from diagnosis.